DARIZMETINIB
UNII Q2HX6A3UDW

Substance Identification & Data

This profile provides standardized clinical and technical data for Darizmetinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q2HX6A3UDW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2369583-33-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q2HX6A3UDW

CAS Registry Number

2369583-33-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DARIZMETINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H17F2N5O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WBNMARNYIFMNEP-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C199030

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

139369660

Unique identification number in the NCBI database of chemical substances.

INN ID

12490

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(=O)(c1c2c([nH]n1)ncc(c2)-c3ccncc3)c4c(F)c(NS(CCC)(=O)=O)c(F)cc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Darizmetinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.